JLGH Fall 2024 Recap
Q&A for Extended Learning
Q: What are the World Professional Association for Transgender Health (WPATH) Standards of Care guidelines to begin gender-affirming hormone therapy in adults (≥18 yo)?
A: Patients should have marked and sustained gender incongruence, the ability to consent to starting therapy and understanding of reproductive impact, and appropriate co-management of their mental and physical health conditions, especially ones that could negatively affect or be negatively affected by hormone therapy.
Read the article.
Q: How can we differentiate ADHD from comorbid conditions in pediatric patients?
A: Rule out language barriers and developmental delay; use more than one screening tool to tease out, for example, symptoms of anxiety or autism; inquire about social and family issues; and try parent management training before prescribing medications, focusing on the symptoms that cause the most impairment.
Q: What are potential complications of improperly treated mastoiditis?
A: Potential complications include permanent hearing loss, nerve palsy, osteomyelitis, petrositis, Gradenigo’s syndrome, labyrinthitis, and intracranial extension — including meningitis and subdural empyema, sigmoid sinus thrombosis, and abscess formation.
Read the article.
Q: Although breast cancer screening recommendations differ, what are the U.S. Preventative Services Task Force recommendations regarding breast cancer screening?
A: The Task Force recommends that all women get screened for breast cancer every other year, starting at age 40 and continuing through age 74. This is a “B” recommendation.
|